Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-30

Clinical Trial Update: A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cetuximab plus raltitrexed as maintenance therapy in advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)
  • Raltitrexed (Raltitrexed)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN